Calendar

Week of Apr 20, 2026

Apr 25, 2026phase 0 trial completion73d agoExegenesis Bio Inc — EXG-202 (Phase 0 Trial Completion)EXG-202

Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration

full page →EXG-202 →source: globaldata

Week of Apr 27, 2026

Apr 29, 2026phase 0 trial completion69d agoDana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)atezolizumab

Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer

full page →atezolizumab →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoKunming Yan'an Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System. Indication: Pain

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoRuijin Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System, Dermatology. Indication: Burns, Pain, Sedation

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoSecond Affiliated Hospital of Anhui Medical University — yingtao shujie paste (Phase 0 Trial Completion)yingtao shujie paste

Therapy area: Oncology, Women's Health. Indication: Breast Cancer, Breast Hyperplasia

full page →yingtao shujie paste →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System. Indication: Delirium

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoCivil Aviation General Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Cardiovascular, Respiratory. Indication: Ischemia Reperfusion Injury, Lung Disease

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoShanghai Jiao Tong University — insulin (Phase 0 Trial Completion)insulin

Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders

full page →insulin →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoFoundation for the Promotion of Health and Biomedical Research of Valencia — Aquacel Ag + (Phase 0 Trial Completion)Aquacel Ag +

Therapy area: Dermatology. Indication: Pressure Ulcers

full page →Aquacel Ag + →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoYangzhou No.1 People's Hospital — dexamethasone (Phase 0 Trial Completion)dexamethasone

Therapy area: Gastrointestinal. Indication: Post Operative Nausea And Vomiting

full page →dexamethasone →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoHefei First People’s Hospital — ergothioneine (Phase 0 Trial Completion)ergothioneine

Therapy area: Cardiovascular. Indication: Atherosclerosis

full page →ergothioneine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System. Indication: Delirium

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoUniversity of Utah — micronized progesterone (Phase 0 Trial Completion)micronized progesterone

Therapy area: Central Nervous System. Indication: Substance (Drug) Abuse

full page →micronized progesterone →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System. Indication: Delirium

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoNational Key Research and Development Program — undisclosed sodium glucose cotransporter 2 inhibitor (Phase 0 Trial Completion)undisclosed sodium glucose cotransporter 2 inhibitor

Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes

full page →undisclosed sodium glucose cotransporter 2 inhibitor →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoUniversity of Southern California — methylprednisolone (Phase 0 Trial Completion)MEDROL

Therapy area: Immunology. Indication: Drug Hypersensitivity Reactions

full page →MEDROL →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoKey Projects of Science and Technology Department of Sichuan Province — dantrolene (Phase 0 Trial Completion)dantrolene

Therapy area: Cardiovascular. Indication: Ischemia, Myocardial Ischemia, Ventricular Arrhythmia

full page →dantrolene →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoBaylor College of Medicine — glycine (Phase 0 Trial Completion)glycine

Therapy area: Central Nervous System. Indication: Alzheimer's Disease

full page →glycine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoUniversity of Pennsylvania — ubidecarenone (Phase 0 Trial Completion)ubidecarenone

Therapy area: Central Nervous System, Gastrointestinal. Indication: Crohn's Disease (Regional Enteritis), Fatigue

full page →ubidecarenone →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoJiangsu Maoxing Technology Co Ltd — MT-026 (Phase 0 Trial Completion)MT-026

Therapy area: Oncology. Indication: Glioma

full page →MT-026 →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoFirst Affiliated Hospital of Anhui Medical University — esketamine (Phase 0 Trial Completion)esketamine

Therapy area: Central Nervous System, Oncology. Indication: Post-Operative Pain, Thyroid Cancer

full page →esketamine →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoInner Mongolia Aerospace Hospital — (bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) (Phase 0 Trial Completion)(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12)

Therapy area: Cardiovascular, Gastrointestinal. Indication: Atherosclerosis, Irritable Bowel Syndrome

full page →(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) →source: globaldata

Apr 30, 2026phase 0 trial completion68d agoFuning County People's Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Central Nervous System, Gastrointestinal. Indication: Post Operative Nausea And Vomiting, Post-Operative Pain

full page →dexmedetomidine →source: globaldata

Week of Apr 20, 2026

Week of Apr 27, 2026